Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 6Neoplasms 3Graft vs Host Disease 2Myelodysplastic Syndromes 1Leukemia 1Hematologic Neoplasms 1Arthritis 1Anemia, Refractory 1

Interventions

Nutrition Assessment 2Collagenases 2upadacitinib 1tocilizumab 1Vaccines 1Transcutaneous Electric Nerve Stimulation 1Saline Solution 1Resistance Training 1Omeprazole 1Naproxen 1Melphalan 1Lysine Acetyltransferase 5 1Injections, Intra-Articular 1Immune Checkpoint Inhibitors 1Herpes Zoster Vaccine 1Febuxostat 1Exercise Therapy 1Colchicine 1Cari-D-Tect 1Arthroplasty, Replacement, Shoulder 1Arthroplasty, Replacement, Elbow 1Allopurinol 1Adalimumab 1Abatacept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Arthritis × Abatacept × Clear all
NCT01351480 2017-03-13

Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients

Arthritis & Rheumatic Disease Specialties Research

Phase 3 Completed
34 enrolled 8 charts

Arthritis, Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡